— Conference Call Scheduled for 4:30 p.m. ET —
— Company to Provide Update on Commercial Launch of Phexxi and Pivotal Phase 3 Trial of EVO100 —
PR Newswire
SAN DIEGO
,
Feb. 18, 2021
/PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM) will hold a webcast and conference call to discuss the Company’s financial results and business highlights for the fourth quarter and year ended
December 31, 2020
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The live webcast and related slide presentation can be accessed through the Investors section of its
website
or directly at
https://evofem.investorroom.com/Q4YE2020Results
. Please connect to the Company’s website at least 15 minutes prior to the start of the call to download any software that may be required.
If participating by phone, please dial in approximately 15 minutes prior to the start of the call.
The webcast will be archived at
https://evofem.investorroom.com/Q4YE2020Results
. A telephone replay will be available for 24 hours after the call at (855) 859-2056 (U.S.) or (404) 537-3406 (International), conference ID 9928997.
About Evofem Biosciences, Inc.
Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company’s first commercial product,
Phexxi
®
(lactic acid, citric acid and potassium bitartrate)
, is the first and only hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The Company’s lead product candidate, EVO100, is being evaluated for the prevention of urogenital
Chlamydia trachomatis
and
Neisseria gonorrhoeae
infection in women in the ongoing Phase 3 clinical trial, ‘
EVOGUARD
.’ For more information, please visit
www.evofem.com
.
Phexxi
®
is a registered trademark of Evofem Biosciences, Inc.
Investor Relations Contact
Amy Raskopf
Evofem Biosciences, Inc.
[email protected]
Mobile: (917) 673-5775
Media Contact
Ellen Thomas
Evofem Biosciences, Inc.
[email protected]
Mobile: (718) 490-3248
View original content to download multimedia:
http://www.prnewswire.com/news-releases/evofem-biosciences-to-report-fourth-quarter-and-year-end-2020-results-and-provide-corporate-update-on-thursday-march-4-2021-301230571.html
SOURCE Evofem Biosciences, Inc.
